Pharmacogenomics and end-organ susceptibility to injury in the perioperative period.

Abstract excerpt

Genomic medicine has provided new mechanistic understanding for many complex diseases over the last 5-10 years. More recently genomic approaches have been applied to the perioperative paradigm, facilitating identification of patients at high risk for adverse events, as well as those who will respond better/worse to specific pharmacologic therapies. The consistent biological theme emerging is that while...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anesthesia
• Share to Genetic Variation
• Share to Genomics